Regeneron (REGN) announced that the U.S. Food and Drug Administration has accepted for review the resubmission of the Biologics License ...

The repositioned brand highlights ABM’s commitment to operational excellence, workforce enablement, and delivering measurable ...

Attendees will have a completely new experience compared to previous conferences. Sessions will be more flexible and ...